kims involvement was to secure the interim analysis and that was secured.
enrollments are handled by Molly Wade.
FDA issues handled by Debra Krinder head of regulatory
either way , was a good move to bring in kim and wish her the best in her future.
lets hope for no drama with the stock tomorrow
- Forums
- ASX - By Stock
- SHC
- kim olesson leaves position head of clinical affairs
kim olesson leaves position head of clinical affairs, page-3
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)